HIV Patients on Efavirenz Have Increased Risks
of Suicidality
While the HIV drug efavirenz has long been associated with central nervous system side-effects, little data has existed on its risk for increasing suicidality. Now, a new combined analysis of AIDS trials involving more than 5,000 treatment-naïve adults suggests the drug can more than double the risk of suicide ideation, attempts, and completions, although the overall rate remains fairly low.
Here are the details.